Wesley Farris

3.2k total citations · 2 hit papers
11 papers, 2.7k citations indexed

About

Wesley Farris is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Wesley Farris has authored 11 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 4 papers in Molecular Biology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Wesley Farris's work include Alzheimer's disease research and treatments (9 papers), Nuclear Receptors and Signaling (4 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). Wesley Farris is often cited by papers focused on Alzheimer's disease research and treatments (9 papers), Nuclear Receptors and Signaling (4 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). Wesley Farris collaborates with scholars based in United States and Ireland. Wesley Farris's co-authors include Dennis J. Selkoe, Matthew P. Frosch, Malcolm A. Leissring, Rudolph E. Tanzi, Elizabeth A. Eckman, Christopher B. Eckman, Yang Chang, Suzanne Y. Guénette, Loren Lindsley and Alice Y. Chang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Neuron.

In The Last Decade

Wesley Farris

10 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo

2003 1.2k citations Wesley Farris, Yang Chang et al. Proceedings of the National Academy of Sciences profile →
Enhanced Proteolysis of β-Amyloid in APP Transgenic Mice Prevents Plaque Formation, Secondary Pathology, and Premature Death

2003 585 citations Malcolm A. Leissring, Wesley Farris et al. Neuron profile →

Peers

Countries citing papers authored by Wesley Farris

Since Specialization

Citations

This map shows the geographic impact of Wesley Farris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wesley Farris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wesley Farris more than expected).

Fields of papers citing papers by Wesley Farris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wesley Farris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wesley Farris. The network helps show where Wesley Farris may publish in the future.

Co-authorship network of co-authors of Wesley Farris

This figure shows the co-authorship network connecting the top 25 collaborators of Wesley Farris. A scholar is included among the top collaborators of Wesley Farris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wesley Farris. Wesley Farris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Loss of Neprilysin Function Promotes Amyloid Plaque Formation and Causes Cerebral Amyloid Angiopathy 2007 ·American Journal Of Pathology ·Wesley Farris, Sonja G. Schütz, John R. Cirrito, Ganesh M. Shankar, Xiaoyan Sun, (unknown), Malcolm A. Leissring, Dominic M. Walsh, Wei Qiao Qiu, David M. Holtzman, Dennis J. Selkoe	126
2	Decreased Catalytic Activity of the Insulin-degrading Enzyme in Chromosome 10-Linked Alzheimer Disease Families 2007 ·Journal of Biological Chemistry ·Minji Kim, Louis B. Hersh, Malcolm A. Leissring, Martin Ingelsson, Toshifumi Matsui, Wesley Farris, Alice Lu, Bradley T. Hyman, Dennis J. Selkoe, Lars Bertram, Rudolph E. Tanzi	80
3	Effects of prolonged angiotensin-converting enzyme inhibitor treatment on amyloid β-protein metabolism in mouse models of Alzheimer disease 2007 ·Neurobiology of Disease ·Matthew L. Hemming, Dennis J. Selkoe, Wesley Farris	102
4	Effects of Chronic Glucocorticoid Administration on Insulin-Degrading Enzyme and Amyloid-Beta Peptide in the Aged Macaque 2005 ·Journal of Neuropathology & Experimental Neurology ·J. Jacob Kulstad, Pamela J. McMillan, James B. Leverenz, David G. Cook, Pattie S. Green, Elaine R. Peskind, Charles W. Wilkinson, Wesley Farris, Pankaj Mehta, Suzanne Craft	77
5	Alternative Splicing of Human Insulin-Degrading Enzyme Yields a Novel Isoform with a Decreased Ability To Degrade Insulin and Amyloid β-Protein 2005 ·Biochemistry ·Wesley Farris, Malcolm A. Leissring, Matthew L. Hemming, Alice Y. Chang, Dennis J. Selkoe	71
6	Partial Loss-of-Function Mutations in Insulin-Degrading Enzyme that Induce Diabetes also Impair Degradation of Amyloid β-Protein 2004 ·American Journal Of Pathology ·Wesley Farris, (unknown), Malcolm A. Leissring, Elizabeth A. Eckman, Lars Bertram, Christopher B. Eckman, Rudolph E. Tanzi, Dennis J. Selkoe	202
7	Alternative translation initiation generates a novel isoform of insulin-degrading enzyme targeted to mitochondria 2004 ·Biochemical Journal ·Malcolm A. Leissring, Wesley Farris, (unknown), Danos C. Christodoulou, Marcia C. Haigis, Leonard Guarente, Dennis J. Selkoe	132
8	Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo breakdown → 2003 ·Proceedings of the National Academy of Sciences ·Wesley Farris, (unknown), Yang Chang, Loren Lindsley, Elizabeth A. Eckman, Matthew P. Frosch, Christopher B. Eckman, Rudolph E. Tanzi, Dennis J. Selkoe, Suzanne Y. Guénette	1191
9	Enhanced Proteolysis of β-Amyloid in APP Transgenic Mice Prevents Plaque Formation, Secondary Pathology, and Premature Death breakdown → 2003 ·Neuron ·Malcolm A. Leissring, Wesley Farris, Alice Y. Chang, Dominic M. Walsh, (unknown), Xiaoyan Sun, Matthew P. Frosch, Dennis J. Selkoe	585
10	Kinetics of Amyloid β-Protein Degradation Determined by Novel Fluorescence- and Fluorescence Polarization-based Assays 2003 ·Journal of Biological Chemistry ·Malcolm A. Leissring, Alice Lu, Margaret M. Condron, David B. Teplow, Ross L. Stein, Wesley Farris, Dennis J. Selkoe	98
11	A TECHNIQUE FOR STUDYING EPITHELIZATION IN MAN, WITH EVIDENCE FOR ITS ACCELERATION BY CERTAIN FATTY ACIDS. 1964 ·PubMed ·(unknown), Wesley Farris, (unknown), Ernest Marshall	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact